62 related articles for article (PubMed ID: 21677618)
1. Fluoxetine as a treatment for post-traumatic stress disorder.
Xu JJ; Chan MJ; Yang YC
Neurosciences (Riyadh); 2011 Jul; 16(3):257-62. PubMed ID: 21677618
[TBL] [Abstract][Full Text] [Related]
2. Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trial.
Martenyi F; Soldatenkova V
Eur Neuropsychopharmacol; 2006 Jul; 16(5):340-9. PubMed ID: 16356696
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and posttraumatic stress disorder: a pilot study assessing changes in SF-36 scores before and after treatment in a placebo-controlled trial of fluoxetine.
Malik ML; Connor KM; Sutherland SM; Smith RD; Davison RM; Davidson JR
J Trauma Stress; 1999 Apr; 12(2):387-93. PubMed ID: 10378176
[TBL] [Abstract][Full Text] [Related]
4. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study.
Martenyi F; Brown EB; Caldwell CD
J Clin Psychopharmacol; 2007 Apr; 27(2):166-70. PubMed ID: 17414240
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine in posttraumatic stress disorder.
van der Kolk BA; Dreyfuss D; Michaels M; Shera D; Berkowitz R; Fisler R; Saxe G
J Clin Psychiatry; 1994 Dec; 55(12):517-22. PubMed ID: 7814344
[TBL] [Abstract][Full Text] [Related]
6. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder.
McRae AL; Brady KT; Mellman TA; Sonne SC; Killeen TK; Timmerman MA; Bayles-Dazet W
Depress Anxiety; 2004; 19(3):190-6. PubMed ID: 15129422
[TBL] [Abstract][Full Text] [Related]
7. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
[TBL] [Abstract][Full Text] [Related]
8. Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study.
Connor KM; Sutherland SM; Tupler LA; Malik ML; Davidson JR
Br J Psychiatry; 1999 Jul; 175():17-22. PubMed ID: 10621763
[TBL] [Abstract][Full Text] [Related]
9. Effects of mirtazapine in patients with post-traumatic stress disorder in Korea: a pilot study.
Bahk WM; Pae CU; Tsoh J; Chae JH; Jun TY; Chul-Lee ; Kim KS
Hum Psychopharmacol; 2002 Oct; 17(7):341-4. PubMed ID: 12415552
[TBL] [Abstract][Full Text] [Related]
10. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
Brady KT; Clary CM
Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
[TBL] [Abstract][Full Text] [Related]
11. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
Davidson J; Rothbaum BO; Tucker P; Asnis G; Benattia I; Musgnung JJ
J Clin Psychopharmacol; 2006 Jun; 26(3):259-67. PubMed ID: 16702890
[TBL] [Abstract][Full Text] [Related]
12. A randomized double-blind clinical trial on analgesic efficacy of fluoxetine for persistent somatoform pain disorder.
Luo YL; Zhang MY; Wu WY; Li CB; Lu Z; Li QW
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1522-5. PubMed ID: 19733606
[TBL] [Abstract][Full Text] [Related]
13. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial.
Spivak B; Strous RD; Shaked G; Shabash E; Kotler M; Weizman A
J Clin Psychopharmacol; 2006 Apr; 26(2):152-6. PubMed ID: 16633143
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of the efficacy of treatments for posttraumatic stress disorder.
Watts BV; Schnurr PP; Mayo L; Young-Xu Y; Weeks WB; Friedman MJ
J Clin Psychiatry; 2013 Jun; 74(6):e541-50. PubMed ID: 23842024
[TBL] [Abstract][Full Text] [Related]
15. Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale.
Davidson J; Baldwin DS; Stein DJ; Pedersen R; Ahmed S; Musgnung J; Benattia I; Rothbaum BO
Int Clin Psychopharmacol; 2008 Sep; 23(5):299-303. PubMed ID: 18703940
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta-analysis.
Yi ZM; Liu F; Zhai SD
Int J Clin Pract; 2010 Aug; 64(9):1310-7. PubMed ID: 20653802
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sertraline in posttraumatic stress disorder secondary to interpersonal trauma or childhood abuse.
Stein DJ; van der Kolk BA; Austin C; Fayyad R; Clary C
Ann Clin Psychiatry; 2006; 18(4):243-9. PubMed ID: 17162624
[TBL] [Abstract][Full Text] [Related]
19. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans.
Hertzberg MA; Feldman ME; Beckham JC; Kudler HS; Davidson JR
Ann Clin Psychiatry; 2000 Jun; 12(2):101-5. PubMed ID: 10907802
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder.
Martenyi F; Brown EB; Zhang H; Koke SC; Prakash A
Br J Psychiatry; 2002 Oct; 181():315-20. PubMed ID: 12356658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
